Fig. 5.
(A) Overall survival for lymphomas with high BCL2 protein expression (n = 63) and low/absent BCL2 protein expression (n = 93). (B) DFS for lymphomas with high BCL2 protein expression (n = 32) and low/absent BCL2 protein expression (n = 56).
(A) Overall survival for lymphomas with high BCL2 protein expression (n = 63) and low/absent BCL2 protein expression (n = 93). (B) DFS for lymphomas with high BCL2 protein expression (n = 32) and low/absent BCL2 protein expression (n = 56).
